Abiomed (ABMD) Halted Ahead of FDA Meeting on Blood Pumps
- Top 10 News for 4/25 - 4/29: Merger Madness!; Valeant Hies New Boss; Icahn's Exit of Apple Could be Telling Sign
- Halliburton (HAL), Baker Hughes (BHI) Said to Plan Calling Off $28B Merger Agreement
- Wall Street falls as earnings weigh; Dow, S&P up for month
- Amazon.com (AMZN) Tops Q1 EPS by 49c; Issues Q2 Outlook
- Exclusive: Yahoo's bidder shortlist points to cash deal -sources
Abiomed, Inc. (NASDAQ: ABMD) halted ahead of FDA advisory committee meeting over nonroller-type cardiopulmonary bypass blood pumps.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sarepta Therapeutics (SRPT) Pushes Higher Following Positive Article on Approval
- Baxalta (BXLT) Receives Positive EMA CHMP Opinion for Expanded HyQvia Indication
- ARIAD Pharma's (ARIA) Brigatinib Granted FDA Orphan Drug Status
Create E-mail Alert Related CategoriesFDA, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!